Primary Care Clinics in Eva, AL Accepting Medicare
3 Primary Care Clinics found. Showing 1 - 3
 Eva Health Center Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 4208 Eva Rd, Eva, AL 35621 Phone: 256-796-5260 Fax: 256-796-4639 |
Eva Familt Health Clinic Llc Clinic/Center - Primary Care Medicare: Medicare Enrolled Practice Location: 4208 Eva Rd Ste B, Eva, AL 35621 Phone: 256-735-4154 |
Central North Alabama Health Services, Inc. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4208 Eva Rd, Suite B, Eva, AL 35621 Phone: 256-796-7264 Fax: 256-796-2148 |
News Archive
Opexa Therapeutics reports net loss of $1,433,922 for year ended December 31, 2009
Opexa Therapeutics, Inc., a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), today reported financial results for the year ended December 31, 2009 and provided an update on its progress.
Researchers assess familial risks for MS using population registers, health care registries
Even though multiple sclerosis is largely caused by genetic factors, the risk of patients' relatives developing the disease is lower than previously assumed. This is the conclusion of a new population registry-based study, published in the scientific journal Brain.
Generic Hyzaar and Cozaar litigation: Court of Appeals rules in favor of Teva Pharmaceutical Industries
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Court of Appeals for the District of Columbia Circuit has ruled in Teva's favor by overturning a July 31, 2009, district court decision which held that Teva forfeited 180-day marketing exclusivity for its generic versions of Merck's antihypertensive agents Hyzaar® (hydrochlorothiazide; losartan potassium) and Cozaar® (losartan potassium).
New understanding on meningitis cause
A specific protein on the surface of a common bacterial pathogen allows the bacteria to leave the bloodstream and enter the brain, initiating the deadly infection known as meningitis. The new finding, which may guide development of improved vaccines to protect those most vulnerable, including young infants and the elderly, is now available online in the Journal of Experimental Medicine.
› Verified 7 days ago